Sagimet Biosciences Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Foster City, CA
SGMT chart
What traders are saying about $SGMT
Latest postsSagimet Biosciences Inc. news
- Sagimet Biosciences Inc. - Series A Estimates – NASDAQ:SGMT
TradingView ·
- Wall Street Analysts Think Sagimet Biosciences Inc. (SGMT) Could Surge 168.24%: Read This Before Placing a Bet
Yahoo Finance ·
- Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne
Yahoo Finance ·
- Sagimet Biosciences starts key Phase 3 trial fo...
Pluang ·
- Form 8K Sagimet Biosciences Inc For: 22 October By Investing.com
Investing.com Nigeria ·
- Wedbush Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $28
Moomoo ·
- Sagimet Biosciences Updates Pipeline: Acne Phase 3 Underway, TVB-3567 Phase 2 Planned
TradingView ·
- First patient dosed as Sagimet (SGMT) begins an acne trial set to include 450 teens.
Stock Titan ·
- Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne
Yahoo Finance ·
- Sagimet Biosciences Announces First Patient Dosed in AURORA
GlobeNewswire ·
- Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet
Seeking Alpha ·
- After Plunging 27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
Yahoo Finance ·
Sagimet Biosciences Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $2.0M | – |
| Net income | -$51.0M | -$45.6M | -$27.9M | -$30.5M |
| Diluted EPS | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
| Total assets (year end) | $116.5M | $160.3M | $96.7M | $33.0M |
| Cash and equivalents (year end) | $35.0M | $75.8M | $75.1M | $158,000 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sagimet Biosciences Inc.
- Ticker
- SGMT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1400118
- Former names
- 3-V Biosciences, Inc.
Frequently asked questions
What exchange is Sagimet Biosciences Inc. listed on?
Sagimet Biosciences Inc. trades on the Nasdaq under the ticker symbol SGMT.
What industry is Sagimet Biosciences Inc. in?
Sagimet Biosciences Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Sagimet Biosciences Inc. headquartered?
Sagimet Biosciences Inc.'s business address on file with the SEC is in Foster City, CA.
When does Sagimet Biosciences Inc.'s fiscal year end?
Sagimet Biosciences Inc.'s fiscal year ends on December 31.
How much revenue did Sagimet Biosciences Inc. report?
Sagimet Biosciences Inc. reported $2.0M in revenue for calendar year 2023, according to its SEC filings.